GyreOx will participate widely within its industry sector, attending both scientific and business development conferences, and publicising its technical and commercial achievements.
We are delighted to announce that GyreOx has been shortlisted into the final round in the 'Best Start-up BioTech Company' category of the 2020 OBN Awards.